FDA pushes back Ascendis' dwarfism drug decision date by three months
FDA pushes back Ascendis' dwarfism drug decision date by three months
Contenido no disponible. Consulta la fuente original.
FDA pushes back Ascendis' dwarfism drug decision date by three months
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.